Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo

被引：0
|
作者：
Hrzenjak, A. [1 ]
Moinfar, F. [2 ]
Kremser, M. L. [2 ]
Strohmeier, B. [2 ]
Petru, E. [3 ]
Zatloukal, K. [2 ]
Denk, H. [2 ]
机构：
[1] Med Univ Graz, Inst Internal Med, Clin Dept Pulmonol, Graz, Austria
[2] Med Univ Graz, Dept Pathol, Graz, Austria
[3] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)71055-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
248
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [31] Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo
    Wu, Zhenkai
    Ma, Chao
    Shan, Zhi
    Ju, Yaping
    Li, Siyu
    Zhao, Qinghua
    JOURNAL OF BUON, 2013, 18 (04): : 1032 - 1037
  • [32] Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo
    Hiroki Sawa
    Hiromi Murakami
    Masaoki Kumagai
    Matsuyoshi Nakasato
    Shigeru Yamauchi
    Nozomu Matsuyama
    Yasuo Tamura
    Akira Satone
    Wataru Ide
    Ikuo Hashimoto
    Hajime Kamada
    Acta Neuropathologica, 2004, 107 : 523 - 531
  • [33] Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo
    Sawa, H
    Murakami, H
    Kumagai, M
    Nakasato, M
    Yamauchi, S
    Matsuyama, N
    Tamura, Y
    Satone, A
    Ide, W
    Hashimoto, I
    Kamada, H
    ACTA NEUROPATHOLOGICA, 2004, 107 (06) : 523 - 531
  • [34] Resveratrol Suppresses Uterine Fibroid Cell Growth in Vivo and in Vitro
    Chen, Hsin-Yuan
    Hsia, Shih-Min
    ANNALS OF NUTRITION AND METABOLISM, 2019, 75 : 251 - 251
  • [35] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor:: Effects on gene expression and growth of glioma cells in vitro and in vivo
    Yin, Dong
    Ong, John M.
    Hu, Jinwei
    Desmond, Julian C.
    Kawamata, Norihiko
    Konda, Bindu M.
    Black, Keith L.
    Koeffler, H. Phillip
    CLINICAL CANCER RESEARCH, 2007, 13 (03) : 1045 - 1052
  • [36] Initial testing of the histone deacetylase inhibitor Vorinostat by the Pediatric Preclinical Testing Program
    Houghton, Peter J.
    Maris, John M.
    Courtright, Joshua
    Friedman, Henry
    Keir, Stephen T.
    Lock, Richard B.
    Carol, Hernan
    Gorlick, Richard
    Kolb, E. Anders
    Keshelava, Nino
    Reynolds, Patrick
    Morton, Christopher L.
    Smith, Malcolm A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3600S - 3601S
  • [37] Mechanisms of tumour-selective apoptosis induced by the histone deacetylase inhibitor vorinostat
    Bolden, J. E.
    Shi, W.
    Smyth, G. K.
    Cluse, L. A.
    Johnstone, R. W.
    EJC SUPPLEMENTS, 2008, 6 (09): : 86 - 86
  • [38] Histone Deacetylase Inhibitor, Vorinostat, as an Enhancer of Gemcitabine Therapy for Resistant Pancreatic Tumors
    Green, L. J.
    Koshkina, N.
    Curley, S. A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S156 - S156
  • [39] HISTONE DEACETYLASE INHIBITOR, VALPROIC ACID INHIBITS GLIOMA ANGIOGENESIS IN VITRO AND IN VIVO IN THE BRAIN
    Osuka, Satoru
    Takano, Shingo
    Yamamoto, Tetsuya
    Ishikawa, Eiichi
    Matsumura, Akira
    NEURO-ONCOLOGY, 2009, 11 (06) : 962 - 962
  • [40] Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo
    Liu, Xinyu
    Li, Wenjing
    Xu, Licheng
    Chen, Xiaoxue
    Zhao, Rui
    Guo, Yan
    Ge, Jingchun
    Yang, Zhenming
    Li, Liang
    Zhang, Jiarui
    Cao, Jing
    Shao, Yue
    Guo, Xinyue
    Tian, Linli
    Liu, Ming
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2023, 158
12345